Addressing Substance Use Disorders in Transplant Candidates and Recipients

Sunday, April 26, 2026

8:30 AM - 9:45 AM PT

Location: Gaslamp, Level 2

Presenter(s)

Thomas Bottyan, MD

Addiction Psychiatrist
VA Northern California
Mather, California
DA

Divya Ayyala-somayajula, MD MAS

Assistant Professor of Medicine
Thomas Jefferson University
PHILADELPHIA, Pennsylvania
ST

Steven Tate, MD, MSc, FASAM, FACP

Clinical Assistant Professor
Stanford University School of Medicine
San Francisco, California
Gargi Bhattacharya, MD

Fellow, Addiction Medicine
Stanford University School of Medicine
Stanford, California

Slides

Non-presenting author(s)

Deirdra Kelly, MD

Psychiatry Resident
University of California Davis
Sacramento, California

This advanced, case-based workshop explores the evaluation and management of substance use disorders in transplant candidates and recipients, with a focus on real-world clinical challenges. Through multidisciplinary discussion, participants will consider approaches to alcohol, opioid, tobacco, and cannabis use in the peri- and post-transplant settings. Patient perspectives will be included to highlight lived experiences and inform care approaches.

Learning Objectives:

Learners will be able to:

Identify appropriate approaches to evaluating and treating substance use disorders in patients before and after solid organ transplantation.
Apply multidisciplinary approaches to address complex clinical scenarios involving substance use in transplant patients, integrating perspectives from hepatology, addiction medicine, and patient experiences.
Develop strategies for screening, counseling, and medication management to support recovery and long-term transplant outcomes in patients with current or past substance use.

Disclosure(s):

Thomas Bottyan, MD: No financial relationships to disclose

Divya Ayyala-somayajula, MD MAS: No financial relationships to disclose

Steven Tate, MD, MSc, FASAM, FACP: No financial relationships to disclose

Gargi Bhattacharya, MD: No financial relationships to disclose

Deirdra Kelly, MD: No financial relationships to disclose